Filing Details

Accession Number:
0001209191-22-057585
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-17 16:46:16
Reporting Period:
2022-11-15
Accepted Time:
2022-11-17 16:46:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1658247 Crinetics Pharmaceuticals Inc. CRNX Pharmaceutical Preparations (2834) 263744114
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1886575 F. Stephen Betz C/O Crinetics Pharmaceuticals, Inc.
10222 Barnes Canyon Road, Bldg 2
San Diego CA 92121
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-11-15 3,126 $18.72 88,094 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date.